Amphastar Pharmaceuticals (AMPH) Other Operating Expenses (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Other Operating Expenses of $11.9 million for Q1 2026, down 40.65% year-over-year from $20.1 million in Q1 2025, and down 62.77% quarter-over-quarter from $32.0 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Other Operating Expenses (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Other Operating Expenses history runs 14 years deep, the most recent figure standing at $11.9 million for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 40.65% year-over-year to $11.9 million; the TTM figure through Mar 2026 stood at $81.9 million (up 6.47% YoY), while the FY2025 annual figure was $85.8 million, up 16.14% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $11.9 million, down from $32.0 million in the prior quarter.
- The five-year high for Other Operating Expenses was $32.0 million in Q4 2025, with the low at $5.5 million in Q4 2022.
- The 5-year median for Other Operating Expenses is $16.2 million (2022), against an average of $16.0 million.
- Peak annual rise in Other Operating Expenses reached 273.15% in 2023, while the deepest fall reached 70.53% in 2023.
- Amphastar Pharmaceuticals' Other Operating Expenses stood at $5.5 million in 2022, then soared by 273.15% to $20.4 million in 2023, then jumped by 31.01% to $26.8 million in 2024, then gained by 19.77% to $32.0 million in 2025, then tumbled by 62.77% to $11.9 million in 2026.
- Business Quant data shows AMPH's Other Operating Expenses at $11.9 million in Q1 2026, $32.0 million in Q4 2025, and $27.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - |
| 10 | Amphastar Pharmaceuticals | 931.14 Mn | 641.02 Mn | 93.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.34 Mn |
| Mar 31, 2026 | 11.93 Mn |
| Dec 31, 2025 | 32.04 Mn |
| Sep 30, 2025 | 27.72 Mn |
| Jun 30, 2025 | 10.24 Mn |
| Mar 31, 2025 | 20.10 Mn |
| Dec 31, 2024 | 26.75 Mn |
| Sep 30, 2024 | 11.28 Mn |
| Jun 30, 2024 | 18.82 Mn |
| Mar 31, 2024 | 9.37 Mn |
| Dec 31, 2023 | 20.42 Mn |
| Sep 30, 2023 | 6.41 Mn |
| Jun 30, 2023 | 6.72 Mn |
| Mar 31, 2023 | 7.11 Mn |
| Dec 31, 2022 | 5.47 Mn |
| Sep 30, 2022 | 18.51 Mn |
| Jun 30, 2022 | 22.80 Mn |
| Mar 31, 2022 | 16.22 Mn |
| Dec 31, 2021 | -26.16 Mn |
| Sep 30, 2021 | 10.76 Mn |